RE: Cavendish Research Note18 Jun 2026 09:50
There are one or two points concerning funding P1 that I find inconsistent, or not the accepted wisdom of shareholders here.
First, to answer your question, MgBRG96, on page 27 the report states, " In terms of asset values, we take the FY27E NPV10% (real basis) for Orom-Cross and the Gulu downstream facility. In deriving our valuations, we apply a 0.75x P/NPV risk multiple on the assumption that Phase 1 funding will be completed in 3QCY26E...."
Second, Cavendish write on p26 that, "Pending actual developments, we assume that: — US$55m of equity will be raised (covering both P1 construction and overheads) via the issuance of c529m shares priced at 8.0p (the current share price, rounded) during 2HCY26. " What? Only if to a strategic investor, which may well be the case, but not via placings, and in any case, this assumption is at odds with MR's oft-stated intent not to dilute shareholders at the group level but instead at the project level.
And again, on p25, "Blencowe plans to raise US$45m of equity to finance P1 construction, while the US$125m required for P2 is expected to be funded predominantly via debt or DFI-style routes. "
They MUST have a strategic investor in mind, to do this. That would be excellent news for all of us, but a change of strategy for BRES.